Home Cart Sign in  
Chemical Structure| 2924573-90-8 Chemical Structure| 2924573-90-8

Structure of FX-909
CAS No.: 2924573-90-8

Chemical Structure| 2924573-90-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

FX-909 is a covalent inverse agonist of peroxisome proliferator-activated receptor gamma (PPARG), used in tumor research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of FX-909

CAS No. :2924573-90-8
Formula : C17H10F2N2O3S
M.W : 360.33
SMILES Code : N#CC1=CC=C(S(=O)(C)=O)C(C(NC2=C3C(F)=CC(F)=C2)=CC3=O)=C1
MDL No. :N/A

Safety of FX-909

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05929235 Advanced Solid Tumors Cancer|A... More >>dvanced Urothelial Carcinoma|Oral Drug Administration|Open Label Less << PHASE1 RECRUITING 2027-01-30 HonorHealth, Scottsdale, Arizo... More >>na, 85258, United States|Yale Cancer Center, New Haven, Connecticut, 06519, United States|Mass General Cancer Center, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Memorial Slone Kettering Cancer Center, New York, New York, 10065, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27514, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|New Experimental Therapeutics of San Antonio (NEXT), San Antonio, Texas, 78229, United States|South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, 78229, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.78mL

0.56mL

0.28mL

13.88mL

2.78mL

1.39mL

27.75mL

5.55mL

2.78mL

 

Historical Records

Categories